Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
Trial details
- Registry ID
- NCT04845178
- Drugs studied
- ABP-450
TrialRedline tracks 4 clinical trials sponsored by AEON Biopharma, Inc.: 4 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsNCT04845178 | ABP-450 | Completed | 2024-06-19Actual |
| Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaNCT04871451 | ABP-450 | Completed | 2023-07-24Actual |
| A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaNCT04849988 | ABP-450 | Completed | 2022-07-11Actual |
| Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionNCT05016661 | ABP-450 | Terminated | 2024-07-31Actual |
Names as written in the registry records.